Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.
about
The role of NKT cells in tumor immunityHow do natural killer T cells help B cells?Autoimmune disease triggered by infection with alphaproteobacteriaEnhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implicationsSynthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Antitumor Responses of Invariant Natural Killer T CellsImmune Modulation in Hematologic MalignanciesThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationImaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial ImmunityThe regulatory role of invariant NKT cells in tumor immunitySelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?The systemic cytokine environment is permanently altered in multiple myelomaCancer immunotherapy via dendritic cellsSublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramidePlasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.All-trans-retinoic acid and the glycolipid α-galactosylceramide combined reduce breast tumor growth and lung metastasis in a 4T1 murine breast tumor model.Development of a qPCR method to rapidly assess the function of NKT cells.Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.Spleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cellsKLRG+ invariant natural killer T cells are long-lived effectors.Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and InflammationDesigning vaccines based on biology of human dendritic cell subsetsEfficacy of ABX196, a new NKT agonist, in prophylactic human vaccinationDendritic cell subsets in health and disease.Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma modelCombination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.Invariant NKT cells are required for antitumor responses induced by host-versus-graft responsesDeveloping understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.Synthesis and Biological Activities of 5-Thio-α-GalCers.The split personality of NKT cells in malignancy, autoimmune and allergic disordersThe Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsThe immune microenvironment of myeloma
P2860
Q24648939-312CC812-A241-48C4-87D8-CEB1C0D35DDFQ24650966-0776D6B3-658F-4D49-B0A5-C6CE544588BCQ24655779-7C73CDE6-40AB-48F4-87B9-C4F33F30136AQ24685895-C53CE839-005E-40B2-889E-8F392BB1CD2CQ26748456-78AADB9F-DAA6-4D08-92CB-698925371D14Q26768699-5F5D6D81-0FE6-4463-AA97-F7689BC17AFCQ26778648-2E430732-2BB9-45B6-BBDE-B05213B63021Q26796307-41B2472A-357E-458F-ADF2-7E2227EE519DQ26797344-DEAD4E03-77C6-4664-BEFE-B2A4D727DE69Q26799999-14029CE7-975D-4193-BFC2-4F94D538B9FCQ27023425-2402D6EF-5B17-47E7-8F01-C4DF2C8DACB5Q28287583-4C0D5BC6-0BA9-493C-9BCC-0251EF683BC4Q28489028-3A669048-EE56-4912-B6AE-64A4C7A49CFEQ29615444-2689FD76-A7E2-4499-B97D-BD78F0F8DDE9Q31153121-DC8E05B7-9741-438B-AA4D-C379C6B80AF4Q33389529-B2A65106-79D4-4FE6-AFCB-203F6673F66AQ33409032-91840E4C-AB0E-4047-9453-886A59B17344Q33720359-750441EC-6F32-4FF4-A349-E3DA9D662B8FQ33733648-0D470F49-8D5E-4E72-807E-7479B53EBC2BQ33769503-92B712A1-F737-4387-B57B-6F0FA2ED056DQ33815383-3D63C1A2-C509-435D-9442-3957CFA2C143Q33882880-3EF68DCE-C8FB-4D62-AA0A-11AB6F0CF2B8Q33997622-27E2E059-C51C-4151-BF34-25850B44163DQ34069630-F97CF78A-CAC7-4D30-BB72-736C272747D3Q34103244-F04D9804-5D00-4D5B-BE19-5D27AF3D3D52Q34120251-A4A824C0-663D-4498-931E-1154B626BCC3Q34275397-563C0E6E-CFD5-4CC1-A92E-4053DB8999EEQ34288977-066CA74B-104B-415C-B48C-8DE6A5B54FF5Q34289152-AAB41902-9794-4561-991C-56ED049B27F0Q34517948-688A5D61-DB41-4AAB-9A49-D68AD2200EC4Q34582889-A7741F92-4536-425A-B397-415DF5B48B4DQ34761156-3F70F3A3-2758-4864-BE63-8911B56508CFQ34934974-46CFEFEC-3B3D-4469-90A0-2E594A16F84BQ34983932-249091CD-DA65-4C93-8F43-F424B600E852Q35034135-63FC01EF-8561-42B9-AA7A-6B86FF567B81Q35127172-42A5A92D-DD8E-4BE9-AA29-86AD476CB68AQ35559790-30016662-9A35-4ECD-BBCD-494B3E57840FQ35590727-8E013AA0-EA6E-43A9-919A-BF2D8AB4F4EFQ35600087-C9C77CED-83C3-4ADA-A38A-1C7714B27C94Q35603152-CEAC70F4-C85C-49E9-8426-16C1900001C9
P2860
Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sustained expansion of NKT cel ...... ritic cells in cancer patients
@nl
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@ast
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@en
type
label
Sustained expansion of NKT cel ...... ritic cells in cancer patients
@nl
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@ast
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@en
prefLabel
Sustained expansion of NKT cel ...... ritic cells in cancer patients
@nl
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@ast
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@en
P2093
P2860
P3181
P356
P1476
Sustained expansion of NKT cel ...... itic cells in cancer patients.
@en
P2093
Aisha Hutchinson
Anjli Kukreja
David H Chang
Hani Hassoun
Jennifer Shay
John Connolly
Joseph Krasovsky
Kelly Kirchhoff
Keren Osman
Kunihiko Hayashi
P2860
P304
P3181
P356
10.1084/JEM.20042592
P407
P577
2005-05-01T00:00:00Z